Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

INTRODUCTION: Early neurological deterioration (END) is a forecast factor in poor outcomes in minor strokes. END's prevalence and forecast factors in minor strokes caused by small artery occlusion (SAO) are still unclear. PATIENTS AND METHOD: We retrospectively analyzed 451 patients with minor stroke (NIHSS ≤ 5) caused by SAO hospitalized within an initial 24 hours at BachMai Hospital's stroke center. END was defined as conditions with an elevated two or more NIHSS points within an initial 72 hours. The primary outcome included the determination of the END incidence. The secondary outcome identified forecast factors for END through multivariate logistic regression analyses, and therapeutic impacts of antiplatelet and thrombolytic treatments. RESULTS: END occurred in 9.5% (43/451) of patients (62.7% male, mean age 63.8±11.8 years). Independent forecast included admission SBP ≥150mmHg (OR=1.99; 95%CI:1.01-3.94;p=0.048), diabetes history (OR=0.58; 95%CI:1.05-4.33;p=0.036), admission blood glucose ≥14mmol/L (OR=2.99; 95%CI:1.05-8.54;p=0.04), and internal capsule infarction (OR=2.23; 95%CI:1.01-4.92;p=0.048). The patients group admitted within 4.5 hours, DAPT has significantly lower END risk compared to SAPT (OR=0.079; 95%CI:0.007-0.939;p=0.04) and altepase (OR=0.013; 95%CI:0.01-0.12;p<0.01). END risk was similar between SAPT and altepase (p=0.074). DISCUSSION AND CONCLUSION: END is a 9.5% incidence in minor acute ischemic stroke due to SAO. Independent forecasts are admission SBP and blood glucose, diabetes history, and internal capsule infarction. The DAPT group has significantly lower END risk than the SAPT and alteplase groups.

Original publication

DOI

10.1016/j.jstrokecerebrovasdis.2025.108331

Type

Journal article

Journal

J Stroke Cerebrovasc Dis

Publication Date

25/04/2025

Keywords

alteplase, dual antiplatelet therapy, early neurological deterioration, minor stroke, single antiplatelet therapy, small artery occlusion